angiotensin ii has been researched along with ag-490 in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 15 (50.00) | 29.6817 |
2010's | 8 (26.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Ali, MS; Bernstein, KE; Dirksen, LB; Hayzer, DJ; Marrero, MB; Sayeski, PP | 1 |
Baker, KM; Conrad, KM; Dostal, DE; Hunt, RA; McWhinney, CD | 1 |
Baker, K; Dostal, D; McWhinney, CD | 1 |
Florian, JA; Monroe, KM; Watts, SW | 1 |
Ju, H; Liang, H; Marrero, MB; Venema, RC; Venema, VJ; Wang, X | 1 |
Ali, MS; Bernstein, KE; Frank, SJ; Kim, SO; Lyles, M; Safavi, A; Sayeski, PP | 1 |
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
Bencherif, M; Marrero, MB; Shaw, S | 1 |
Clark, BJ; Dawson, KL; Feltzer, RE; Hudson, EA; Li, J | 1 |
Amiri, F; Banes, AK; Jenkins, J; Marrero, MB; Pollock, DM; Redd, H; Shaw, S | 1 |
Bencherif, M; Bhatti, BS; Marrero, MB; Papke, RL; Shaw, S | 1 |
Ingelfinger, JR; Moini, B; Zhang, SL | 1 |
Guo, J; Ingelfinger, JR; Moini, B; Zhang, SL | 1 |
Clark, BJ; Li, J | 1 |
Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y | 1 |
Sayeski, PP; Wallace, TA; Xia, SL | 1 |
Chen, JW; Cui, YH; Pan, H; Wang, TH; Xiang, QL | 1 |
Dominici, FP; Giani, JF; Gironacci, MM; Muñoz, MC; Peña, C; Turyn, D | 1 |
Banes-Berceli, AK; Ketsawatsomkron, P; Marrero, MB; Ogbi, S; Patel, B; Pollock, DM | 1 |
Huang, W; Jiang, FX; Wu, W; Wu, YL; Yu, LF; Zhong, J; Zhu, JY | 1 |
Clark, MA; Kandalam, U | 1 |
Huang, B; Jiang, T; Pi, L; Zhou, QS | 1 |
Al-Azawi, H; Banes-Berceli, AK; Brands, MW; Femminineo, D; Hill-Pyror, C; Proctor, D; Qu, H; Webb, RC | 1 |
Cambi, GE; Djeokeng, MM; Faggian, G; Fiaschi, T; Lucchese, G; Modesti, A; Modesti, PA; Sani, G | 1 |
Chou, CH; Chuang, LY; Guh, JY; Lu, CY | 1 |
Chen, P; Cui, Y; Huang, B; Jiang, T; Jiang, Y; Liang, Y; Ouyang, J; Zhou, Q | 1 |
Shen, JH; Tan, JH; Wang, H; Xu, MC; Ying, H; Zhang, DF | 1 |
Chang, J; Dai, F; Hu, Z; Li, B; Liu, H; Ren, W; Ruan, Y; Wang, Z; Wu, Z | 1 |
Jiang, X; Li, SH; Li, ZH; Liang, JX; Liao, X; Liu, HW; Wu, F; Wu, YD; Xu, Y; Yan, JX | 1 |
Cai, SY; Fu, YL; Lin, Q; Peng, FH; Tao, L; Wang, Q; Zheng, NZ | 1 |
30 other study(ies) available for angiotensin ii and ag-490
Article | Year |
---|---|
Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Binding Sites; COS Cells; Enzyme Inhibitors; Janus Kinase 2; Molecular Sequence Data; Nitriles; Peptide Fragments; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Signal Transduction; Transfection; Tyrosine; Tyrphostins | 1997 |
The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; DNA-Binding Proteins; Heart; Imidazoles; Janus Kinase 2; Losartan; Myocardium; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrosine; Tyrphostins | 1997 |
Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Heart Ventricles; Janus Kinase 2; Milk Proteins; Molecular Sequence Data; Myocardium; Nitriles; Phosphorylation; Prolactin; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; STAT5 Transcription Factor; Trans-Activators; Tyrosine; Tyrphostins | 1998 |
Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
Topics: Angiotensin II; Animals; Aorta; Enzyme Activation; Flavonoids; Genistein; In Vitro Techniques; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Nitriles; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tyrphostins; Vasoconstriction | 1998 |
Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcineurin; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Janus Kinase 2; Muscle, Smooth, Vascular; Okadaic Acid; Oligonucleotides, Antisense; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Phosphatase 2; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tacrolimus; Trans-Activators; Tyrphostins | 1999 |
A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn.
Topics: Angiotensin II; Animals; Cells, Cultured; COS Cells; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Janus Kinase 2; Muscle, Smooth, Vascular; Mutation; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; src Homology Domains; Surface Plasmon Resonance; Transfection; Tyrphostins | 1999 |
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins | 2001 |
Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Bungarotoxins; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Janus Kinase 2; Neuroprotective Agents; Nicotine; Nicotinic Agonists; PC12 Cells; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptors, Nicotinic; Serine; Signal Transduction; Tyrosine; Tyrphostins | 2002 |
Janus kinase 2 and calcium are required for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells.
Topics: Adrenal Cortex; Angiotensin II; Calcium; Cell Line; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Genes, Reporter; Humans; Immunoblotting; Janus Kinase 2; Luciferases; Phosphoproteins; Progesterone; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Radioimmunoassay; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tyrphostins | 2003 |
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; DNA-Binding Proteins; Enzyme Inhibitors; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney Glomerulus; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrphostins | 2004 |
The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiotensin II; Animals; Apoptosis; Bridged Bicyclo Compounds; Drosophila Proteins; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Receptors, Nicotinic; Serine; Tyrosine; Tyrphostins | 2004 |
Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor.
Topics: Angiotensin II; Animals; Anthracenes; Blotting, Western; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Flavonoids; Genistein; Imidazoles; Kidney; Losartan; Mice; Microscopy, Fluorescence; Onium Compounds; PAX2 Transcription Factor; Phosphorylation; Plasmids; Pyridines; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factors; Tyrphostins; Up-Regulation | 2004 |
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; Cell Division; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Antibody Technique; Gene Expression; Genistein; Imidazoles; Janus Kinase 2; Kidney Tubules, Proximal; PAX2 Transcription Factor; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyridines; Rats; Signal Transduction; Transcription Factors; Transformation, Genetic; Tyrphostins; Up-Regulation; Vasoconstrictor Agents | 2004 |
Janus kinase 2 signaling in the angiotensin II-dependent activation of StAR expression.
Topics: Angiotensin II; Cell Line, Tumor; Cycloheximide; Enzyme Inhibitors; Humans; Janus Kinase 2; Phosphoproteins; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transcriptional Activation; Tyrphostins; Zona Glomerulosa | 2004 |
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents | 2005 |
Jak2 tyrosine kinase prevents angiotensin II-mediated inositol 1,4,5 trisphosphate receptor degradation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Calcium; Calcium Channels; Cells, Cultured; Enzyme Inhibitors; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Inositol 1,4,5-Trisphosphate Receptors; Janus Kinase 2; Muscle, Smooth, Vascular; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Tyrphostins | 2005 |
Raloxifene plus 17beta-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade.
Topics: Angiotensin II; Animals; Blotting, Western; Breast; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Endothelial Cells; Estradiol; Estrogen Receptor beta; Female; Fluorescent Antibody Technique; Humans; Janus Kinases; Muscle, Smooth, Vascular; Phosphorylation; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2007 |
Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
Topics: Androstadienes; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Insulin; Insulin Receptor Substrate Proteins; Janus Kinase 2; Losartan; Male; Myocardium; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction; Tyrphostins; Wortmannin | 2007 |
Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrasentan; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Male; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Pyrrolidines; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Tyrphostins; Vasodilation | 2007 |
Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells.
Topics: Angiotensin II; Blotting, Western; Cell Survival; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Humans; Matrix Metalloproteinase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Tumor Cells, Cultured; Tyrphostins; Vascular Endothelial Growth Factor A | 2009 |
Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Astrocytes; Brain Stem; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Imidazoles; Interleukin-6; Janus Kinase 2; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; STAT3 Transcription Factor; Time Factors; Tyrphostins; Vasoconstrictor Agents | 2010 |
[Role of angiotensin II and JAK2 signal pathway in transdifferentation of renal tubular cells in mice after acute ischemic followed by reperfusion].
Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Imidazoles; Janus Kinase 2; Kidney Tubules; Male; Pyridines; Rats; Rats, Wistar; Renin-Angiotensin System; Reperfusion Injury; RNA, Messenger; Signal Transduction; Tyrphostins | 2009 |
Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.
Topics: Angiotensin II; Animals; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension; Infusions, Intravenous; Janus Kinase 2; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2011 |
Impaired JAK2-induced activation of STAT3 in failing human myocytes.
Topics: Angiotensin II; Blotting, Western; Cells, Cultured; Enzyme Inhibitors; Heart Failure; Humans; Interleukin-6; Janus Kinase 2; Muscle Cells; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2012 |
Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Benzamides; Cells, Cultured; Chromones; Dioxoles; Fibronectins; Gene Expression Regulation; Glucose; Janus Kinase 2; LLC-PK1 Cells; Molecular Sequence Data; Morpholines; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, G-Protein-Coupled; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Swine; Transcription, Genetic; Transforming Growth Factor beta; Tyrphostins | 2013 |
Cell atavistic transition: Paired box 2 re-expression occurs in mature tubular epithelial cells during acute kidney injury and is regulated by Angiotensin II.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Antineoplastic Agents; CD24 Antigen; Cell Line; Epithelial Cells; Gene Expression Regulation; Imidazoles; Janus Kinase 2; Kidney Tubules; PAX2 Transcription Factor; Pyridines; Rats; Reperfusion Injury; Tyrphostins; Vasoconstrictor Agents | 2014 |
Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Nucleus; Cells, Cultured; Histone Deacetylase 2; Hydroxamic Acids; Janus Kinase 2; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Pressure; Rats; Signal Transduction; Tyrphostins | 2014 |
JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury.
Topics: Acute Lung Injury; Adult; Aged; Angiotensin II; Animals; Aortic Dissection; Apoptosis; Cells, Cultured; Endothelial Cells; Female; Humans; Interleukin-22; Interleukins; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Middle Aged; Protein Kinase Inhibitors; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2017 |
A novel role of angiotensin II in epidermal cell lineage determination: Angiotensin II promotes the differentiation of mesenchymal stem cells into keratinocytes through the p38 MAPK, JNK and JAK2 signalling pathways.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Anthracenes; Bone Marrow Cells; Cell Differentiation; Cell Lineage; Cell Movement; Imidazoles; Janus Kinase 2; Janus Kinases; Keratinocytes; Losartan; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tyrphostins | 2019 |
GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function.
Topics: Angiotensin II; Animals; Cardiomegaly; Connexin 43; Down-Regulation; Gap Junctions; Janus Kinase 2; Male; Membrane Potential, Mitochondrial; Mitochondria; Myocardium; Organelle Biogenesis; Rats, Inbred WKY; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Valsartan | 2021 |